UBS raised the firm’s price target on Axis Capital (AXS) to $115 from $105 and keeps a Buy rating on the shares. UBS likes the defensive nature of P&C insurance heading into 1Q25 results, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
- Axis Capital price target lowered to $114 from $120 at Keefe Bruyette
- Axis Capital price target raised to $120 from $118 at Keefe Bruyette
- Axis Capital price target raised to $118 from $115 at Keefe Bruyette
- Axis Capital management to meet with Roth MKM
- Axis Capital board approves up to $400M share repurchase program